ClinicalTrials.Veeva

Menu

The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock

C

Chengdu Fifth People's Hospital

Status

Unknown

Conditions

Septic Shock

Treatments

Other: fluid chanllenge

Study type

Interventional

Funder types

Other

Identifiers

NCT03661268
2018-002(yan)-02

Details and patient eligibility

About

Fluid challenge is often carried out in septic shock patients. Its responsiveness usually requires invasive monitoring. The pulmonary artery catheter(PAC) is the most effective means of monitoring.To use non-invasive methods is very tempting. Investigators hypothesize that venous-to-arterial carbon dioxide difference,venous-to-arterial carbon oxygen difference, central venous-arterial carbon dioxide to arterial-venous oxygen content ratio and Central Venous SO2 variations provides feasible estimation on fluid responsiveness in septic shock patients.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more than 18 years old; less than 75 years old ICU patients
  • Septic shock
  • Monitored with pulmonary artery catheter (Swan-Ganz catheter)
  • The decision of fluid challenge made by the treating physician

Exclusion criteria

  • Evidence of fluid overload
  • Pregnancy
  • Recently participated in other studies
  • Severe heart failure

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Septic shock
Experimental group
Description:
Patients (at least 18 years of age, no more than 75 years old) with refractory hypotension secondary to sepsis who, at the discretion of treating physicians, required fluid challenge in the presence of pulmonary artery catheter. Refractory hypotension was defined as need of vasopressors to maintain systolic blood pressure (SBP) no less than 90 mmHg despite adequate fluid resuscitation.
Treatment:
Other: fluid chanllenge

Trial contacts and locations

1

Loading...

Central trial contact

xiang xiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems